January 18, 2023

Reply to: Comment on: Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma

No abstract 

Pediatr Blood Cancer. 2023 May;70(5):e30206. doi: 10.1002/pbc.30206. Epub 2023 Jan 18.

NO ABSTRACT

PMID:36651715 | DOI:10.1002/pbc.30206

 

 

Share via: